Desminopathies in muscle disease

Journal of Pathology

Volumn 204, Issue 4, 2004, Pages 418-427

  Paulin, Denise ^a   Huet, Alexis ^a   Khanamyrian, Luiza ^a   Xue, Zhigang ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Alpha B crystallin; Desmin; Knockout mice; Muscle; Mutation; Synemin

Indexed keywords

ALPHA CRYSTALLIN; CYTOSKELETON PROTEIN; DESMIN; MUSCLE PROTEIN; MYOCYTE ENHANCER FACTOR 2; MYOD PROTEIN; PLECTIN; TRANSCRIPTION FACTOR SP1;

AUTOSOMAL DOMINANT INHERITANCE; CARDIOMYOPATHY; CELL STRUCTURE; DISEASE COURSE; GENE MUTATION; GENETIC REGULATION; HUMAN; KNOCKOUT MOUSE; MITOCHONDRION; MOUSE; MUSCLE DISEASE; MUSCLE FIBRIL; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN INTERACTION; RESPIRATORY FAILURE; REVIEW; SARCOMERE; SKELETAL MUSCLE; TRANSGENIC MOUSE;

ANIMALS; CYTOSKELETON; DESMIN; HUMANS; MODELS, ANIMAL; MODELS, BIOLOGICAL; MUSCLE PROTEINS; MUSCLE, SKELETAL; MUSCLE, SMOOTH, VASCULAR; MUSCULAR DISEASES; MUTATION;

EID: 7944234954     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.1639     Document Type: Review

References (56)

1. Goebel HH, Fardeau M. Desmin - protein surplus myopathies. Neuromuscul Disord 2002; 12: 687-692.
2. Goebel HH. Desmin-related neuromuscular disorders. Muscle Nerve 1995; 18: 1306-1320.
3. Goldfarb LG, Vicart P, Goebel HH, Dalakas MC. Desmin myopathy. Brain 2004; 127: 723-734.
4. Lazarides E, Hubbard BD. Immunological characterization of the subunit of the 100 Å filaments from muscle cells. Proc Natl Acad Sci U S A 1976; 73: 4344-4348.
5. Li ZL, Lilienbaum A, Butler-Browne G, Paulin D. Human desmin-coding gene: complete nucleotide sequence, characterization and regulation of expression during myogenesis and development. Gene 1989; 78: 243-254.
6. Dubin RA, Wawrousek EF, Piatigorsky J. Expression of the murine alpha B-crystallin gene is not restricted to the lens. Mol Cell Biol 1989; 9: 1083-1091.
7. Vicart P, Caron A, Guicheney P, et al. A missense mutation in the alpha B-crystallin chaperone gene causes a desmin-related myopathy. Nature Genet 1998; 20: 92-95.
8. Fardeau M, Godet-Guillain J, Tome FM, et al. A new familial muscular disorder demonstrated by the intra-sarcoplasmic accumulation of a granulo-filamentous material which is dense on electron microscopy. Rev Neurol (Paris) 1978; 134: 411-425.
9. Fardeau M, Vicart P, Caron A, et al. Familial myopathy with desmin storage seen as a granulo-filamentar, electron-dense material with mutation of the alpha B-cristallin gene. Rev Neurol (Paris) 2000; 156: 497-504.
10. Selcen D, Engel AG. Myofibrillar myopathy caused by novel dominant negative alpha B-crystallin mutations. Ann Neurol 2003; 54: 804-810.
11. Viegas-Pequignot E, Li ZL, Dutrillaux B, Apiou F, Paulin D. Assignment of human desmin gene to band 2q35 by nonradioactive in situ hybridization. Hum Genet 1989; 83: 33-36.
12. Li Z, Marchand P, Humbert J, Babinet C, Paulin D. Desmin sequence elements regulating skeletal muscle-specific expression in transgenic mice. Development 1993; 117: 947-959.
13. Li Z, Paulin D. Different factors interact with myoblast-specific and myotube-specific enhancer regions of the human desmin gene. J Biol Chem 1993; 268: 10403-10415.
14. Mericskay M, Parlakian A, Porteu A, et al. An overlapping CArG/octamer element is required for regulation of desmin gene transcription in arterial smooth muscle cells. Dev Biol 2000; 226: 192-208.
15. Stromer MH. The cytoskeleton in skeletal, cardiac and smooth muscle cells. Histol Histopathol 1998; 13: 283-291.
16. Ishikawa H, Bischoff R, Holtzer H. Mitosis and intermediate-sized filaments in developing skeletal muscle. J Cell Biol 1968; 38: 538-555.
17. Askanas V, Bornemann A, Engel WK. Immunocytochemical localization of desmin at human neuromuscular junctions. Neurology 1990; 40: 949-953.
18. Sealock R, Murnane AA, Paulin D, Froehner SC. Immunochemical identification of desmin in Torpedo postsynaptic membranes and at the rat neuromuscular junction. Synapse 1989; 3: 315-324.
19. Tidball JG. Desmin at myotendinous junctions. Exp Cell Res 1992; 199: 206-212.
20. Thornell LE, Eriksson A. Filament systems in the Purkinje fibers of the heart. Am J Physiol 1981; 241: 291-305.
21. Ferrans VJ, Roberts WC, Shugoll GI, Massumi RA, Ali N. Plasma membrane extensions in intercalated discs of human myocardium and their relationship to partial dissociations of the discs. J Mol Cell Cardiol 1973; 5: 161-169.
22. Thornell LE, Butler-Browne GS, Carlsson E, et al. Cryoultramicrotomy and immunocytochemistry in the analysis of muscle fine structure. Scan Electron Microsc 1986; 4: 1407-1418.
23. Tokuyasu KT. Visualization of longitudinally-oriented intermediate filaments in frozen sections of chicken cardiac muscle by a new staining method. J Cell Biol 1983; 97: 562-565.
24. Thornell LE, Johansson B, Eriksson A, Lehto VP, Virtanen I. Intermediate filament and associated proteins in the human heart: an immunofluorescence study of normal and pathological hearts. Eur Heart J 1984; 5: 231-241.
25. Danowski BA, Imanaka-Yoshida K, Sanger JM, Sanger JW. Costameres are sites of force transmission to the substratum in adult rat cardiomyocytes. J Cell Biol 1992; 118: 1411-1420.
26. Shear CR, Bloch RJ. Vinculin in subsarcolemmal densities in chicken skeletal muscle: localization and relationship to intracellular and extracellular structures. J Cell Biol 1985; 101: 240-256.
27. Georgatos SD, Weber K, Geisler N, Blobel G. Binding of two desmin derivatives to the plasma membrane and the nuclear envelope of avian erythrocytes: evidence for a conserved site-specificity in intermediate filament-membrane interactions. Proc Natl Acad Sci U S A 1987; 84: 6780-6784.
28. Li Z, Colucci-Guyon E, Pincon-Raymond M, et al. Cardiovascular lesions and skeletal myopathy in mice lacking desmin. Dev Biol 1996; 175: 362-366.
29. Li Z, Mericskay M, Agbulut O, et al. Desmin is essential for the tensile strength and integrity of myofibrils but not for myogenic commitment, differentiation, and fusion of skeletal muscle. J Cell Biol 1997; 139: 129-144.
30. Milner DJ, Weitzer G, Tran D, Bradley A, Capetanaki Y. Disruption of muscle architecture and myocardial degeneration in mice lacking desmin. J Cell Biol 1996; 134: 1255-1270.
31. Balogh J, Mericskay M, Li Z, Paulin D, Arner A. Hearts from mice lacking desmin have a myopathy with impaired active force generation and unaltered wall compliance. Cardiovasc Res 2002; 53: 439-450.
32. Linden M, Li Z, Paulin D, Gotow T, Leterrier JF. Effects of desmin gene knockout on mice heart mitochondria. J Bioenerg Biomembr 2001; 33: 333-341.
33. Munoz-Marmol AM, Strasser G, Isamat M, et al. A dysfunctional desmin mutation in a patient with severe generalized myopathy. Proc Natl Acad Sci U S A 1998; 95: 11 312-11 317.
34. Hoffman EP. Desminopathies: good stuff lost, garbage gained, or the trashman misdirected? Muscle Nerve 2003; 27: 643-645.
35. Selcen D, Ohno K, Engel AG. Clinical and genetic analysis of 40 patients with myofibrial myopathy (MFM) abstract. Neurology 2002; 58: A389-A390.
36. Ariza A, Coll J, Fernandez-Figueras MT, et al. Desmin myopathy: a multisystem disorder involving skeletal, cardiac, and smooth muscle. Hum Pathol 1995; 26: 1032-1037.
37. Dagvadorj A, Goudeau B, Hilton-Jones D, et al. Respiratory insufficiency in desminopathy patients caused by introduction of proline residues in desmin C-terminal alpha-helical segment. Muscle Nerve 2003; 27: 669-675.
38. Dalakas MC, Park KY, Semino-Mora C, Lee HS, Sivakumar K, Goldfarb LG. Desmin myopathy, a skeletal myopathy with cardiomyopathy caused by mutations in the desmin gene. N Engl J Med 2000; 342 770-780.
39. Goudeau B, Dagvadorj A, Rodrigues-Lima F, et al. Structural and functional analysis of a new desmin variant causing desmin-related myopathy. Hum Mutat 2001; 18: 388-396.
40. Sjoberg G, Saavedra-Matiz CA, Rosen DR, et al. A missense mutation in the desmin rod domain is associated with autosomal dominant distal myopathy, and exerts a dominant negative effect on filament formation. Hum Mol Genet 1999; 8: 2191-2198.
41. Sugawara M, Kato K, Komatsu M, et al. A novel de novo mutation in the desmin gene causes desmin myopathy with toxic aggregates. Neurology 2000; 55: 986-990.
42. Goldfarb LG, Park KY, Cervenakova L, et al. Missense mutations in desmin associated with familial cardiac and skeletal myopathy. Nature Genet 1998; 19: 402-403.
43. Herrmann H, Strelkov SV, Feja B, et al. The intermediate filament protein consensus motif of helix 2B: its atomic structure and contribution to assembly. J Mol Biol 2000; 298: 817-832.
44. Park KY, Dalakas MC, Semino-Mora C, et al. Sporadic cardiac and skeletal myopathy caused by a de novo desmin mutation. Clin Genet 2000; 57: 423-429.
45. Li D, Tapscoft T, Gonzalez O, et al. Desmin mutation responsible for idiopathic dilated cardiomyopathy. Circulation 1999; 100: 461-464.
46. Dalakas MC, Dagvadorj A, Goudeau B, et al. Progressive skeletal myopathy, a phenotypic variant of desmin myopathy associated with desmin mutations. Neuromuscul Disord 2003; 13: 252-258.
47. Park KY, Dalakas MC, Goebel HH, et al. Desmin splice variants causing cardiac and skeletal myopathy. J Med Genet 2000; 37: 851-857.
48. Titeux M, Brocheriou V, Xue Z, et al. Human synemin gene generates splice variants encoding two distinct intermediate filament proteins. Eur J Biochem 2001; 268: 6435-6449.
49. Xue Z, Cheraud Y, Brocheriou V, et al. The mouse synemin gene encodes three intermediate filament proteins generated by alternative exon usage and different open reading frames. Exp Cell Res 2004; 298: 431-444.
50. Bellin RM, Huiatt TW, Critchley DR, Robson RM. Synemin may function to directly link muscle cell intermediate filaments to both myofibrillar Z-lines and costameres. J Biol Chem 2001; 276: 32 330-32 337.
51. Mizuno Y, Thompson TG, Guyon JR, et al. Desmuslin, an intermediate filament protein that interacts with alpha-dystrobrevin and desmin. Proc Natl Acad Sci U S A 2001; 98: 6156-6161.
52. Schroder R, Pacholsky D, Reimann J, et al. Primary longitudinal adhesion structures: plectin-containing precursors of costameres in differentiating human skeletal muscle cells. Histochem Cell Biol 2002; 118: 301-310.
53. Fuchs E, Weber K. Intermediate filaments: structure, dynamics, function, and disease. Annu Rev Biochem 1994; 63: 345-382.
54. Schroder R, Goudeau B, Simon MC, et al. On noxious desmin: functional effects of a novel heterozygous desmin insertion mutation on the extrasarcomeric desmin cytoskeleton and mitochondria. Hum Mol Genet 2003; 12: 657-669.
55. Kaminska A, Strelkov SV, Goudeau B, et al. Small deletions disturb desmin architecture leading to breakdown of muscle cells and development of skeletal or cardioskeletal myopathy. Hum Genet 2004; 114: 306-313.
56. Strelkov SV, Herrmann H, Geisler N, et al. Conserved segments 1A and 2B of the intermediate filament dimer: their atomic structures and role in filament assembly. EMBO J 2002; 21: 1255-1266.